Product
Dapagliflozin + Metformin HCl
1 clinical trial
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM: A 24-Week, Multicentre, Randomized, Parallel, Interventional, Non-inferiority, Open-label StudyStatus: Recruiting, Estimated PCD: 2025-04-30